Jubilant Pharmova Ltd (BOM:530019)
₹ 1189.65 -35.8 (-2.92%) Market Cap: 188.44 Bil Enterprise Value: 206.36 Bil PE Ratio: 31.87 PB Ratio: 3.17 GF Score: 76/100

Q4 2019 Jubilant Life Sciences Ltd Earnings Call Transcript

May 17, 2019 / 11:30AM GMT
Release Date Price: ₹445.99 (-4.09%)
Operator

Ladies and gentlemen, good day, and welcome to Jubilant Life Sciences Limited Q4 FY '19 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Ravi Agrawal, Head of Investor Relations, Jubilant Life Sciences Limited. Thank you, and over to you, sir.

Ravi Agrawal
Jubilant Life Sciences Limited - Head of IR

Good evening, everybody. I'm Ravi Agrawal, Head of Investor Relations at Jubilant Life Sciences. I thank you again for being with us today on our Q4 and 12 Months FY '19 Earnings Conference Call.

On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari S. Bhartia, Co-Chairman and Managing Director; Mr. Sankaraiah, Executive Director of Finance.

We will begin with opening comments from Mr. Bhartia on the business performance and outlook. Thereafter, Mr. Sankaraiah will share some key thoughts on the financial aspects of our performance. There will be an opportunity at the end of the opening remarks to get your queries addressed by the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot